SBDS-deficiency results in deregulation of reactive oxygen species leading to increased cell death and decreased cell growth
- 26 October 2010
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 55 (6), 1138-1144
- https://doi.org/10.1002/pbc.22700
Abstract
Background Shwachman–Diamond syndrome (SDS) is characterized by reduced hematopoietic and exocrine pancreatic cell numbers and a marked propensity for leukemia. Most patients have mutations in the SBDS gene. We previously reported that SBDS‐deficient cells overexpress Fas, undergo accelerated spontaneous and Fas‐mediated apoptosis and grow slowly. However the mechanism of how SBDS regulates apoptosis remains unknown. Several studies have shown that reactive oxygen species (ROS) regulate cell growth and spontaneous and Fas‐mediated cell death. Therefore, we hypothesized that SBDS‐deficiency disrupts ROS regulation and subsequently increases sensitivity to Fas stimulation and reduced cell growth. Procedure SBDS was knocked down in HeLa cervical cancer cells and TF‐1 myeloid cells using short hairpin RNA. ROS levels were evaluated by oxidation of 2′,7′‐dichlorodihydrofluorescein diacetate. Apoptosis and cell growth were evaluated with and without antioxidants by annexin V/propidium iodide and 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide assays, respectively. Results We found that shRNA mediated SBDS‐knockdown resulted in a significant increase in ROS levels compared to control cells. Fas stimulation further increased ROS levels in the SBDS‐knockdown HeLa cells more than in the controls. Importantly, balancing ROS levels by antioxidants rescued SBDS‐deficient cells from spontaneous and Fas‐mediated apoptosis and reduced cell growth. Conclusions ROS levels are increased in SBDS‐deficient cells, which leads to increased apoptosis and decreased cell growth. Increased baseline and Fas‐mediated ROS levels in SBDS‐deficient cells can enhance the sensitivity to Fas stimulation. By balancing ROS levels, antioxidants can improve cell growth and survival in SBDS‐deficient cells. Pediatr Blood Cancer. 2010;55:1138–1144.Keywords
This publication has 33 references indexed in Scilit:
- p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathwayCancer Letters, 2009
- Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndromeJCI Insight, 2008
- SBDS-deficient cells undergo accelerated apoptosis through the Fas-pathwayHaematologica, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cellsJCI Insight, 2007
- The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNABlood, 2007
- Loss of the Mouse Ortholog of the Shwachman-Diamond Syndrome Gene (Sbds) Results in Early Embryonic LethalityMolecular and Cellular Biology, 2006
- Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: A prospective 5-year follow-up studyExperimental Hematology, 2002
- Shwachman's syndrome. A review of 21 cases.Archives of Disease in Childhood, 1980
- The syndrome of pancreatic insufficiency and bone marrow dysfunctionThe Journal of Pediatrics, 1964